KNOBELMAN DEBORAH 4
4 · Senti Biosciences, Inc. · Filed Feb 2, 2023
Insider Transaction Report
Form 4
KNOBELMAN DEBORAH
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-01+130,000→ 130,000 totalExercise: $1.81Exp: 2033-01-31→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2023, subject to the reporting person's continued service through the applicable vesting date.